MetaCap

eXoZymes (EXOZ) vs Instil Bio (TIL)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Instil Bio (TIL) has outperformed eXoZymes (EXOZ) over the past year, losing 60.2% versus a loss of 81.8%. Instil Bio is the larger company by market cap ($35.5 million vs $27.4 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EXOZ-81.84%TIL-60.20%
+4%-41%-86%
Nov 21, 20251 yearNov 20, 2026
EXOZ-73.88%TIL-80.26%
+89%+0%-88%
Nov 11, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EXOZ versus TIL key metrics
MetricEXOZTIL
Share price$2.91$5.23
Market cap$27.42M$35.47M
1-day change-14.05%-5.77%
YTD return-73.35%-52.45%
1-year return-81.84%-60.20%
5-year return—-98.72%
EPS (TTM)$-1.16$-3.09
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$10.77M
Revenue growth (YoY)—+152.38%
Net income (latest FY)$-9.16M$-71.37M
Operating margin—-745.39%
Net margin—-662.75%
52-week high$16.16$12.92
52-week low$2.81$5.14
Distance from 52-week high-82.02%-59.51%
Analyst consensusstrong_buynone
Avg. price target upside—+33.84%
Average volume10.14K42.02K
Shares outstanding9.44M6.78M
Employees3217
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • TIL has outperformed EXOZ by 21.6 percentage points over the past year.

About eXoZymes

EXOZ stock →

eXoZymes, Inc. operates as a development stage biotechnology company.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 32 employees

About Instil Bio

TIL stock →

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 17 employees

EXOZ vs TIL FAQ

Which is bigger, eXoZymes or Instil Bio?

Instil Bio (TIL) is larger, with a market capitalization of $35.47M compared with $27.42M for eXoZymes (EXOZ).

Which stock has performed better over the past year, EXOZ or TIL?

TIL returned -60.20% over the past 12 months, compared with -81.84% for EXOZ (price return, excluding dividends). Past performance does not predict future results.

Are eXoZymes and Instil Bio in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons